Molecular Templates Inc logo

Molecular Templates Inc

FRA:NZW (USA)  
€ 7.95 (0%) Feb 14
At Loss
P/B:
1.14
Market Cap:
€ 18.52M ($ 19.84M)
Enterprise V:
€ 15.72M ($ 16.84M)
Volume:
-
Avg Vol (2M):
-
Trade In:
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Molecular Templates Inc ( ) from 2007 to Jun 20 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Molecular Templates stock (FRA:NZW) PE ratio as of Jun 20 2024 is 0. More Details

Molecular Templates Inc (FRA:NZW) PE Ratio (TTM) Chart

To

Molecular Templates Inc (FRA:NZW) PE Ratio (TTM) Historical Data

Total 1208
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Molecular Templates PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-20 At Loss 2023-12-12 At Loss
2024-02-14 At Loss 2023-12-11 At Loss
2024-02-13 At Loss 2023-12-08 At Loss
2024-02-12 At Loss 2023-12-07 At Loss
2024-02-09 At Loss 2023-12-06 At Loss
2024-02-08 At Loss 2023-12-05 At Loss
2024-02-07 At Loss 2023-12-04 At Loss
2024-02-06 At Loss 2023-12-01 At Loss
2024-02-05 At Loss 2023-11-30 At Loss
2024-02-02 At Loss 2023-11-29 At Loss
2024-02-01 At Loss 2023-11-28 At Loss
2024-01-31 At Loss 2023-11-27 At Loss
2024-01-30 At Loss 2023-11-24 At Loss
2024-01-29 At Loss 2023-11-23 At Loss
2024-01-26 At Loss 2023-11-22 At Loss
2024-01-25 At Loss 2023-11-21 At Loss
2024-01-24 At Loss 2023-11-20 At Loss
2024-01-23 At Loss 2023-11-17 At Loss
2024-01-22 At Loss 2023-11-16 At Loss
2024-01-19 At Loss 2023-11-15 At Loss
2024-01-18 At Loss 2023-11-14 At Loss
2024-01-17 At Loss 2023-11-13 At Loss
2024-01-16 At Loss 2023-11-10 At Loss
2024-01-12 At Loss 2023-11-09 At Loss
2024-01-11 At Loss 2023-11-08 At Loss
2024-01-10 At Loss 2023-11-07 At Loss
2024-01-09 At Loss 2023-11-06 At Loss
2024-01-08 At Loss 2023-11-03 At Loss
2024-01-05 At Loss 2023-11-02 At Loss
2024-01-04 At Loss 2023-11-01 At Loss
2024-01-03 At Loss 2023-10-31 At Loss
2024-01-02 At Loss 2023-10-30 At Loss
2024-01-01 At Loss 2023-10-27 At Loss
2023-12-29 At Loss 2023-10-26 At Loss
2023-12-28 At Loss 2023-10-25 At Loss
2023-12-27 At Loss 2023-10-24 At Loss
2023-12-25 At Loss 2023-10-23 At Loss
2023-12-22 At Loss 2023-10-20 At Loss
2023-12-21 At Loss 2023-10-19 At Loss
2023-12-20 At Loss 2023-10-18 At Loss
2023-12-19 At Loss 2023-10-17 At Loss
2023-12-18 At Loss 2023-10-16 At Loss
2023-12-15 At Loss 2023-10-13 At Loss
2023-12-14 At Loss 2023-10-12 At Loss
2023-12-13 At Loss 2023-10-11 At Loss

Molecular Templates Inc (FRA:NZW) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. Its pipeline products are MT-6402, MT-8421 and MT-0169.